daunorubicin has been researched along with Histiocytic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgett, SE; Gaca, AM; Heath, JL; Jaffe, R; Wechsler, DS | 1 |
| Lin, FR; Yao, EG | 1 |
1 trial(s) available for daunorubicin and Histiocytic Sarcoma
| Article | Year |
|---|---|
Etoposide-based combination chemotherapy in malignant histiocytosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Etoposide; Female; Histiocytic Sarcoma; Humans; Male; Middle Aged; Prednisone; Remission Induction | 1994 |
1 other study(ies) available for daunorubicin and Histiocytic Sarcoma
| Article | Year |
|---|---|
Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Histiocytic Sarcoma; Humans; Mercaptopurine; Methotrexate; Prednisone; Risk Factors; Vincristine | 2014 |